Table 3 Median and quartile serum concentrations of PFAS in all subjects under covariate status

Males

 12–19

0.10 (0.07,0.20)**

1.00 (0.70,1.60)**

0.50 (0.40,0.70)**

1.30 (1.00,1.70)**

2.40 (1.70,3.50)**

1.00 (0.80,1.40)**

 20–49

0.01 (0.07,0.20)

1.60 (1.10,2.60)

0.60 (0.40,0.80)

1.80 (1.30,2.40)

3.70 (2.50,5.80)

1.90 (1.30,3.00)

 ≥ 50

0.20 (0.07,0.30)

1.80 (1.20,2.90)

0.80 (0.50,1.10)

2.10 (1.40,2.70)

5.60 (3.40,9.20)

2.90 (1.80,4.40)

Females

 12–19

0.07 (0.07,0.20)**

0.70 (0.40,1.30)**

0.40 (0.30,0.60)**

1.00 (0.70,1.40)**

1.70 (1.20,2.30)**

0.70 (0.50,0.90)**

 20–49

0.10 (0.07,0.20)

0.60 (0.40,1.10)

0.40 (0.30,0.70)

1.00 (0.60,1.60)

2.00 (1.20,3.00)

0.80 (0.50,1.30)

 ≥ 50

0.20 (0.10,0.30)

1.30 (0.80,2.20)

0.70 (0.50,1.10)

1.80 (1.20,2.60)

4.00 (2.50,6.50)

1.90 (1.00,3.40)